# Lateral Pancreaticojejunostomy in a Rare Case of Chronic Calcific Pancreatitis With Peripancreatic Pseudocyst in an 18-Year-Old Male: A Case Report

**Authors:** Sandeep Reddy Ramala, Suresh R Chandak, Souvik Sarkar, Raju K Shinde, Meenakshi S Chandak

PMC · DOI: 10.7759/cureus.59843 · 2024-05-07

## TL;DR

This case report describes a rare case of chronic pancreatitis in a young male successfully treated with a lateral pancreaticojejunostomy.

## Contribution

The report highlights the effectiveness of lateral pancreaticojejunostomy in managing chronic calcific pancreatitis in a rare young patient.

## Key findings

- Lateral pancreaticojejunostomy provided excellent early pain relief and low post-operative complications.
- The procedure preserved pancreatic endocrine and exocrine functions.
- The case demonstrates the procedure's potential in treating pancreatic ductal dilatation and chronic pain.

## Abstract

Another name for the Puestow surgery is a lateral pancreaticojejunostomy. The primary pancreatic duct, which runs from the head to the tail of the organ, is opened, exposing the pancreas. In order to allow the pancreas to empty straight into the intestines, the opening of the pancreatic duct is subsequently joined to a tiny intestinal loop. For more than 50 years, this process has been used to effectively relieve pain caused by chronic pancreatitis. This technique has a very low mortality rate and a low rate of surgical complications, and a high success rate. The gradual fibrosis of the pancreas resulting in the loss of exocrine and endocrine function is known as chronic pancreatitis. Intense pain is the disease's most typical symptom. It is unclear what causes the discomfort in chronic pancreatitis. Nonetheless, a large number of these patients have dilated ducts that are made up of intervening structures and saccular dilations, a condition known as the "chain of lakes" phenomenon. Radiological investigations can be used for diagnosis in these patients. Lateral pancreaticojejunostomy is the most effective treatment option for these individuals. Preservation of endocrine and exocrine pancreatic function is another benefit of lateral pancreaticojejunostomy. With lateral pancreaticojejunostomy, chronic fibrocalcific pancreatitis that manifests as pancreatic ductal dilatation and persistent discomfort can be effectively treated. Excellent early outcomes have been observed in terms of pain alleviation as well as post-operative morbidity and mortality; however, the patient's overall outcome and long-term follow-up have not been as well defined.

## Linked entities

- **Diseases:** chronic pancreatitis (MONDO:0005003)

## Full-text entities

- **Diseases:** fibrosis of (MESH:D005355), Calcific Pancreatitis (MESH:C566837), fibrocalcific pancreatitis (MESH:D010195), chronic pancreatitis (MESH:D050500), pain (MESH:D010146), Peripancreatic Pseudocyst (MESH:D010192), ductal dilatation (MESH:D044584), pancreas (MESH:D010190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11162265/full.md

---
Source: https://tomesphere.com/paper/PMC11162265